NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials-Reference-Cited by-同舟云学术

NT‐proBNP as a marker for atrial fibrillation and heart failure in four observational outpatient trials

Published:2021-11-30 Issue:1 Volume:9 Page:100-109
ISSN:2055-5822
Container-title:ESC Heart Failure
language:en
Short-container-title:ESC Heart Failure

Author:

Werhahn Stefanie M.¹²,Becker Christian¹,Mende Meinhard³,Haarmann Helge¹,Nolte Kathleen¹,Laufs Ulrich⁴,Zeynalova Samira³⁵,Löffler Markus³⁵,Dagres Nikolaos⁶,Husser Daniela⁶,Dörr Marcus⁷⁸,Gross Stefan⁷⁸,Felix Stephan B.⁷⁸,Petersmann Astrid⁹,Herrmann‐Lingen Christoph²¹⁰,Binder Lutz²¹¹,Scherer Martin¹²,Hasenfuß Gerd¹²,Pieske Burkert¹³¹⁴¹⁵,Edelmann Frank¹²¹³¹⁴,Wachter Rolf¹²⁴

Affiliation:

1. Clinic for Cardiology and Pneumology University Medical Center Göttingen Göttingen Germany

2. German Centre for Cardiovascular Research (DZHK), partner site Göttingen Göttingen Germany

3. Institute for Medical Informatics, Statistics and Epidemiology (IMISE) University Hospital Leipzig Leipzig Germany

4. Department of Cardiology University Hospital, Leipzig University Leipzig Germany

5. LIFE Research Center for Civilization Diseases Leipzig Germany

6. Department of Electrophysiology Heart Center Leipzig Germany

7. Department of Internal Medicine B University Medicine Greifswald Greifswald Germany

8. German Centre for Cardiovascular Research (DZHK), partner site Greifswald Greifswald Germany

9. Institute of Clinical Chemistry and Laboratory Medicine University Medicine Greifswald Greifswald Germany

10. Department of Psychosomatic Medicine and Psychotherapy University of Oldenburg Medical Centre Oldenburg Germany

11. Institute for Clinical Chemistry/UMG‐Laboratories University Medical Center Göttingen Göttingen Germany

12. Department of Primary Medical Care University Medical Centre Hamburg‐Eppendorf Hamburg Germany

13. Department of Cardiology Charité University Medicine, Campus Virchow Klinikum Berlin Germany

14. German Centre for Cardiovascular Research (DZHK), partner site Berlin Berlin Germany

15. German Heart Center Berlin Germany

Funder

Freistaat Sachsen

European Regional Development Fund

European Commission

Bundesministerium für Bildung und Forschung

Publisher

Wiley

Subject

Cardiology and Cardiovascular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ehf2.13703

Reference39 articles.

1. Heart Failure Association of the European Society of Cardiology practical guidance on the use of natriuretic peptide concentrations

2. 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure

3. How to diagnose heart failure with preserved ejection fraction: the HFA–PEFF diagnostic algorithm: a consensus recommendation from the Heart Failure Association (HFA) of the European Society of Cardiology (ESC)

4. NT-proBNP and BNP: biomarkers for heart failure management

5. Natriuretic peptide plasma concentrations and risk of cardiovascular versus non-cardiovascular events in heart failure with reduced ejection fraction: Insights from the PARADIGM-HF and ATMOSPHERE trials

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Association between N-terminal pro-B-type natriuretic peptide and clinical outcomes in bedridden patients with stroke: a cross-sectional study;BMJ Open;2024-01

2. Fatty Liver Index and the Risk of Atrial Fibrillation in a General Japanese Population　― The Suita Study ―;Circulation Journal;2023-11-24

3. Soluble Suppression of Tumorigenicity 2 (sST2) in Patients with Predominantly Decompensated Right Heart Failure—A Prospective Observational Study;Journal of Clinical Medicine;2023-11-21

4. Relationship of atrial fibrillation and N terminal pro brain natriuretic peptide in heart failure patients;ESC Heart Failure;2023-09-30

5. Atrial arrhythmias and heart failure: A “modern view” of an old paradox;Pacing and Clinical Electrophysiology;2023-04-04